AcuityMD Launches ‘Pipeline’ to Enable MedTech Commercial Teams to Forecast with Accuracy and Improve Sales Planning

AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced the launch of Pipeline, a new module that enables sales representatives to execute on prospects throughout the sales lifecycle, track progress, forecast accurately, and ultimately improve business planning to grow revenue.

AcuityMD’s Pipeline solution addresses the challenges of the complex MedTech sales lifecycle. Healthcare professionals (HCPs) use MedTech products in vastly different ways depending on various factors, such as product type, surgical procedure, clinical preference, patient characteristics, among others. This makes managing opportunities and predicting ongoing product usage extremely complicated since teams often lack solid data to inform sales forecasts and revenue impact for both the remaining and next fiscal years.

“Pipeline is a game-changer as many MedTech companies struggle to manage the unique complexities of selling medical devices without industry-specific technology,” said Michael Monovoukas, co-founder and CEO of AcuityMD. “Traditional CRMs aren’t natively embedded with customer data, and generic software fails to accommodate the nuances of customer management in the MedTech space. As a result, running a sales process across complex customer profiles is often cumbersome, time consuming, and inaccurate, putting business goals at risk and making it difficult to plan.”

AcuityMD customer, Anika Therapeutics, Inc., a global joint preservation MedTech company, sought a single solution to manage customer opportunities and achieve their vision of a centralized sales process. They expanded their partnership with AcuityMD as an early adopter of AcuityMD Pipeline, which brings opportunity capture and management to the unified platform. In 2019, Anika’s sales team used AcuityMD’s Targeting platform to identify and prioritize new prospects.

“With Acuity’s Targeting solution, we were able to surface over 500 relevant surgeons,” said Rob Delp, vice president, U.S. sales, at Anika. “Now that we’ve identified the prospects, we’re leveraging Pipeline to execute on these opportunities faster, forecast more accurately, and deliver on our sales projections by mapping out an end-to-end view of sales cycles in a single source of truth.”

Benefits of AcuityMD Pipeline:

  • Built for MedTech’s unique data and workflows – Pipeline maps to MedTech’s specific data and sales structure, allowing teams to forecast and meet quota more accurately.
  • Unified end-end platform – Pipeline enables sales representatives to identify opportunities, fill their pipeline, and move prospects through the sales cycle in one unified system, making it easier to continuously monitor progress towards quota and close any gaps with fresh opportunities.
  • Fully integrated with MedTech data – Pipeline gives teams ready-to-use information relevant to each opportunity. In addition to saving time on data entry and maintenance, teams have confidence that their forecasts are reliable.
  • Built for Desktop and Mobile – Pipeline is also built with full functional depth on the AcuityMD Mobile App, making it even easier to update and track on the go.

Pipeline is now generally available and part of the AcuityMD platform.

 

SourceAcuityMD

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”